These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24076587)

  • 41. Pharmacological inhibition of Mdm2 triggers growth arrest and promotes DNA breakage in mouse colon tumors and human colon cancer cells.
    Rigatti MJ; Verma R; Belinsky GS; Rosenberg DW; Giardina C
    Mol Carcinog; 2012 May; 51(5):363-78. PubMed ID: 21557332
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A global map of p53 transcription-factor binding sites in the human genome.
    Wei CL; Wu Q; Vega VB; Chiu KP; Ng P; Zhang T; Shahab A; Yong HC; Fu Y; Weng Z; Liu J; Zhao XD; Chew JL; Lee YL; Kuznetsov VA; Sung WK; Miller LD; Lim B; Liu ET; Yu Q; Ng HH; Ruan Y
    Cell; 2006 Jan; 124(1):207-19. PubMed ID: 16413492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
    Tian B; Liu J; Liu B; Dong Y; Liu J; Song Y; Sun Z
    J Cell Physiol; 2011 Dec; 226(12):3433-41. PubMed ID: 21344396
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of the p53 cistrome--DNA binding cooperativity dissects p53's tumor suppressor functions.
    Schlereth K; Heyl C; Krampitz AM; Mernberger M; Finkernagel F; Scharfe M; Jarek M; Leich E; Rosenwald A; Stiewe T
    PLoS Genet; 2013; 9(8):e1003726. PubMed ID: 23966881
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of p53 transactivation domain mutants reveals Acad11 as a metabolic target important for p53 pro-survival function.
    Jiang D; LaGory EL; Kenzelmann Brož D; Bieging KT; Brady CA; Link N; Abrams JM; Giaccia AJ; Attardi LD
    Cell Rep; 2015 Feb; 10(7):1096-109. PubMed ID: 25704813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function.
    Liu W; Konduri SD; Bansal S; Nayak BK; Rajasekaran SA; Karuppayil SM; Rajasekaran AK; Das GM
    J Biol Chem; 2006 Apr; 281(15):9837-40. PubMed ID: 16469747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TC2N, a novel oncogene, accelerates tumor progression by suppressing p53 signaling pathway in lung cancer.
    Hao XL; Han F; Zhang N; Chen HQ; Jiang X; Yin L; Liu WB; Wang DD; Chen JP; Cui ZH; Ao L; Cao J; Liu JY
    Cell Death Differ; 2019 Jul; 26(7):1235-1250. PubMed ID: 30254375
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
    Mirza A; McGuirk M; Hockenberry TN; Wu Q; Ashar H; Black S; Wen SF; Wang L; Kirschmeier P; Bishop WR; Nielsen LL; Pickett CB; Liu S
    Oncogene; 2002 Apr; 21(17):2613-22. PubMed ID: 11965534
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The transcription factor p53: not a repressor, solely an activator.
    Fischer M; Steiner L; Engeland K
    Cell Cycle; 2014; 13(19):3037-58. PubMed ID: 25486564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Germline TP53 mutations result into a constitutive defect of p53 DNA binding and transcriptional response to DNA damage.
    Zerdoumi Y; Lanos R; Raad S; Flaman JM; Bougeard G; Frebourg T; Tournier I
    Hum Mol Genet; 2017 Jul; 26(14):2591-2602. PubMed ID: 28369373
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel p53 rescue compound induces p53-dependent growth arrest and sensitises glioma cells to Apo2L/TRAIL-induced apoptosis.
    Weinmann L; Wischhusen J; Demma MJ; Naumann U; Roth P; Dasmahapatra B; Weller M
    Cell Death Differ; 2008 Apr; 15(4):718-29. PubMed ID: 18202704
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mdm2 promotes Cdc25C protein degradation and delays cell cycle progression through the G2/M phase.
    Giono LE; Resnick-Silverman L; Carvajal LA; St Clair S; Manfredi JJ
    Oncogene; 2017 Dec; 36(49):6762-6773. PubMed ID: 28806397
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oncoprotein E7 from beta human papillomavirus 38 induces formation of an inhibitory complex for a subset of p53-regulated promoters.
    Saidj D; Cros MP; Hernandez-Vargas H; Guarino F; Sylla BS; Tommasino M; Accardi R
    J Virol; 2013 Nov; 87(22):12139-50. PubMed ID: 24006445
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein.
    Liu WL; Midgley C; Stephen C; Saville M; Lane DP
    J Mol Biol; 2001 Nov; 313(4):711-31. PubMed ID: 11697899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A previously identified apoptosis inhibitor iASPP confers resistance to chemotherapeutic drugs by suppressing senescence in cancer cells.
    Li H; Zhang W; Zhao K; Zhao D; Zheng S; Hu Y
    J Biol Chem; 2020 Mar; 295(12):4049-4063. PubMed ID: 32005663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel eIF5A complex functions as a regulator of p53 and p53-dependent apoptosis.
    Li AL; Li HY; Jin BF; Ye QN; Zhou T; Yu XD; Pan X; Man JH; He K; Yu M; Hu MR; Wang J; Yang SC; Shen BF; Zhang XM
    J Biol Chem; 2004 Nov; 279(47):49251-8. PubMed ID: 15371445
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.
    Fornari F; Milazzo M; Chieco P; Negrini M; Marasco E; Capranico G; Mantovani V; Marinello J; Sabbioni S; Callegari E; Cescon M; Ravaioli M; Croce CM; Bolondi L; Gramantieri L
    J Pathol; 2012 Jul; 227(3):275-85. PubMed ID: 22262409
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Variant 1 of KIAA0101, overexpressed in hepatocellular carcinoma, prevents doxorubicin-induced apoptosis by inhibiting p53 activation.
    Liu L; Chen X; Xie S; Zhang C; Qiu Z; Zhu F
    Hepatology; 2012 Nov; 56(5):1760-9. PubMed ID: 22576474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. p53 pulses lead to distinct patterns of gene expression albeit similar DNA-binding dynamics.
    Hafner A; Stewart-Ornstein J; Purvis JE; Forrester WC; Bulyk ML; Lahav G
    Nat Struct Mol Biol; 2017 Oct; 24(10):840-847. PubMed ID: 28825732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The tumor suppressor p53 associates with gene coding regions and co-traverses with elongating RNA polymerase II in an in vivo model.
    Balakrishnan SK; Gross DS
    Oncogene; 2008 Apr; 27(19):2661-72. PubMed ID: 18026140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.